Search for: "MERCK/SCHERING-PLOUGH PHARMACEUTICALS" Results 61 - 72 of 72
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Feb 2012, 11:29 am by Bexis
Schering-Plough Corp., 842 A.2d 174, 177-78 (N.J. [read post]
28 Jun 2007, 10:16 am
Schering-Plough Corp., 842 A.2d 174, 178 (N.J. [read post]
19 Sep 2013, 9:53 am by Bexis
The following post is exclusively the work of the Reed Smith side of the blog.Sometimes the smallest, least significant type of lawsuit can illustrate cracks in the edifice of the largest, most consequential litigation. [read post]
22 Jun 2011, 7:09 am by Peter Rost
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
14 Sep 2011, 12:07 pm by Peter Rost
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
14 Sep 2011, 12:07 pm by Peter Rost
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
14 Sep 2011, 12:08 pm by Peter Rost
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
24 May 2007, 10:40 am
Superior Court, 920 P.2d 1347, 1353 (Cal. 1996) ("if state-of-the-art scientific data concerning the alleged risk was fully disclosed to the FDA and it determined, after review, that the pharmaceutical manufacturer was not permitted to warn. . .the FDA's conclusion that there was, in effect, no known risk is controlling"); Kelso v. [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central… [read post]
16 Aug 2009, 11:23 am
(Editor's Note: This post is based on a Simpson Thacher & Bartlett memorandum, which first appeared as an article in the New York Law Journal.) [read post]
25 Jan 2010, 5:00 am by Beck, et al.
As we said last week, because it’s a Dechert case, we can’t comment directly on Clark v. [read post]